Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide. This narrative Review provides an overview of the current literature to support notion that NAFLD multisystem disease. Convincing evidence shows strong association between and risk developing multiple extrahepatic complications such as type 2 diabetes, cardiovascular (ie, predominant cause mortality in people with N...

Non-alcoholic fatty liver disease (NAFLD) is the commonest liver disease in the western world, but has never been reported in pregnancy before. We suggest that NAFLD should also be considered as a cause for abnormal liver function tests during pregnancy. As NAFLD is driven by insulin resistance, it is biologically plausible that pregnancy may reveal previously subclinical disease. Obstetricians...

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions world on trajectory to become at a global scale. Risk for high prevalence progressiveness include visceral obesity Type 2 diabetes. The conundrum related rapid increase its burden with low awareness among general providers, as well...

introduction worldwide, chronic liver disease is a major cause of morbidity and mortality. causes of elevated serum alanine aminotransferase (alt) levels vary depending on the population under study. the aim of this study is to evaluate the frequency and causes of persistently elevated alt levels in patients of the gastroenterology (gi) clinics in ghaem and emam reza hospitals in mashhad, iran....

Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common chronic liver disease worldwide, afflicting 20-30% of the general population of western countries [1]. It is also currently the most common liver disease in children [2]. NAFLD refers to a wide spectrum of liver damage, which begins with simple steatosis (accumulation of triglyceride filled vesicles in liver cells), a...